Clinical trials
Phase 1/2 Lymphoma, B-Cell trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chongqing Precision Biotech Co., Ltd | 4 |
| Wuhan Sian Medical Technology Co., Ltd | 3 |
| Chinese PLA General Hospital | 2 |
| 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 1 |
| Academic and Community Cancer Research United | 1 |
| Beijing Biohealthcare Biotechnology Co.,Ltd | 1 |
| Centaurus Biopharma Co., Ltd. | 1 |
| Chongqing University Cancer Hospital | 1 |
| Han weidong | 1 |
| Hebei Senlang Biotechnology Inc., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 28 |
| Leukemia, B-Cell | 8 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Burkitt Lymphoma | 5 |
| Lymphoma | 5 |
| Recurrence | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Leukemia | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, Mantle-Cell | 2 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.